By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Ophthalmic steroids with anti-infectives > Pred-g s.o.p. (ophthalmic) > Gentamicin / Prednisolone Ophthalmic Dosage
Ophthalmic steroids with anti-infectives
https://themeditary.com/dosage-information/gentamicin-prednisolone-ophthalmic-dosage-3784.html

Gentamicin / Prednisolone Ophthalmic Dosage

Drug Detail:Pred-g s.o.p. (ophthalmic) (Gentamicin and prednisolone (ophthalmic) [ jen-ta-mye-sin-and-pred-nis-oh-lone-off-thal-mik ])

Drug Class: Ophthalmic steroids with anti-infectives

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Uveitis

Ointment: Apply a small amount (1/2 inch ribbon) to conjunctival sac of affected eye(s) 1 to 3 times a day

Suspension: Instill 1 drop into the conjunctival sac of the affected eye(s) 2 to 4 times a day; during the initial 24 to 48 hours, may increase frequency up to 1 drop every hour if necessary

Comments:

  • A maximum of 20 mL of suspension or a maximum of 8 g of ointment should be prescribed initially and should not be refilled without further evaluation of the patient's condition.
  • If signs/symptoms fail to improve after 2 days of treatment, the patient should be re-evaluated.
  • Care should be taken as to not discontinue therapy prematurely.

Uses: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureaus, Streptococcus pyogenes, S pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens

Usual Adult Dose for Ocular Infection

Ointment: Apply a small amount (1/2 inch ribbon) to conjunctival sac of affected eye(s) 1 to 3 times a day

Suspension: Instill 1 drop into the conjunctival sac of the affected eye(s) 2 to 4 times a day; during the initial 24 to 48 hours, may increase frequency up to 1 drop every hour if necessary

Comments:

  • A maximum of 20 mL of suspension or a maximum of 8 g of ointment should be prescribed initially and should not be refilled without further evaluation of the patient's condition.
  • If signs/symptoms fail to improve after 2 days of treatment, the patient should be re-evaluated.
  • Care should be taken as to not discontinue therapy prematurely.

Uses: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureaus, Streptococcus pyogenes, S pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens

Usual Adult Dose for Bacterial Conjunctivitis

Ointment: Apply a small amount (1/2 inch ribbon) to conjunctival sac of affected eye(s) 1 to 3 times a day

Suspension: Instill 1 drop into the conjunctival sac of the affected eye(s) 2 to 4 times a day; during the initial 24 to 48 hours, may increase frequency up to 1 drop every hour if necessary

Comments:

  • A maximum of 20 mL of suspension or a maximum of 8 g of ointment should be prescribed initially and should not be refilled without further evaluation of the patient's condition.
  • If signs/symptoms fail to improve after 2 days of treatment, the patient should be re-evaluated.
  • Care should be taken as to not discontinue therapy prematurely.

Uses: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureaus, Streptococcus pyogenes, S pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens

Usual Adult Dose for Keratitis

Ointment: Apply a small amount (1/2 inch ribbon) to conjunctival sac of affected eye(s) 1 to 3 times a day

Suspension: Instill 1 drop into the conjunctival sac of the affected eye(s) 2 to 4 times a day; during the initial 24 to 48 hours, may increase frequency up to 1 drop every hour if necessary

Comments:

  • A maximum of 20 mL of suspension or a maximum of 8 g of ointment should be prescribed initially and should not be refilled without further evaluation of the patient's condition.
  • If signs/symptoms fail to improve after 2 days of treatment, the patient should be re-evaluated.
  • Care should be taken as to not discontinue therapy prematurely.

Uses: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureaus, Streptococcus pyogenes, S pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens

Usual Adult Dose for Keratoconjunctivitis

Ointment: Apply a small amount (1/2 inch ribbon) to conjunctival sac of affected eye(s) 1 to 3 times a day

Suspension: Instill 1 drop into the conjunctival sac of the affected eye(s) 2 to 4 times a day; during the initial 24 to 48 hours, may increase frequency up to 1 drop every hour if necessary

Comments:

  • A maximum of 20 mL of suspension or a maximum of 8 g of ointment should be prescribed initially and should not be refilled without further evaluation of the patient's condition.
  • If signs/symptoms fail to improve after 2 days of treatment, the patient should be re-evaluated.
  • Care should be taken as to not discontinue therapy prematurely.

Uses: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureaus, Streptococcus pyogenes, S pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens

Usual Adult Dose for Blepharitis

Ointment: Apply a small amount (1/2 inch ribbon) to conjunctival sac of affected eye(s) 1 to 3 times a day

Suspension: Instill 1 drop into the conjunctival sac of the affected eye(s) 2 to 4 times a day; during the initial 24 to 48 hours, may increase frequency up to 1 drop every hour if necessary

Comments:

  • A maximum of 20 mL of suspension or a maximum of 8 g of ointment should be prescribed initially and should not be refilled without further evaluation of the patient's condition.
  • If signs/symptoms fail to improve after 2 days of treatment, the patient should be re-evaluated.
  • Care should be taken as to not discontinue therapy prematurely.

Uses: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureaus, Streptococcus pyogenes, S pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • For topical ophthalmic use only; this drug should never be injected subconjunctivally nor introduced into the anterior chamber of the eye.
  • Suspension: Shake well before use

Storage requirements:
  • Suspension: Protect from freezing and from heat of 104F (40C) and above.

Monitoring:
  • Ocular: Routinely measure intraocular pressure if this drug is used for 10 days or longer.

Patient advice:
  • Avoid touching the tip of the tube/bottle to eyelids or any other surface; use by more than 1 person may spread infection.
  • Discontinue use and consult a physician if inflammation or pain persists longer than 48 hours or becomes aggravated.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by